No Data
No Data
Revolution Medicines, Inc. (RVMD): Among the Cash-Rich Mid Cap Stocks to Buy Now
H.C. Wainwright Maintains Revolution Medicines(RVMD.US) With Buy Rating, Raises Target Price to $73
Express News | Revolution Medicines, Inc. : H.c. Wainwright Raises Target Price to $73 From $72
J.P. Morgan Maintains Revolution Medicines(RVMD.US) With Buy Rating, Cuts Target Price to $70
A Quick Look at Today's Ratings for Revolution Medicines(RVMD.US), With a Forecast Between $59 to $78
Revolution Medicines' Earnings Call: Positive Progress Amid Rising Costs